M. Ide, Y. Yauchi, T. Iwasawa
FULL PAPER
Methyl (E)-1-Bromo-2-iodo-2-phenylvinyl(phenyl)carbamate (2): A), 57% yield, 148 mg (Method B) as a white solid (recrystalli-
1
71% yield, 361 mg (Method A), 82% yield, 199 mg (Method B), zation from methanol). H NMR (400 MHz, CDCl3): δ = 7.87 (d,
and 90% yield, 208 mg (Method C) as a yellowish white solid J = 7.9 Hz, 2 H), 7.39–7.29 (m, 7 H), 2.96 (s, 3 H), 2.45 (s, 3
1
(recrystallization from methanol). H NMR (400 MHz, CDCl3): δ H) ppm. 13C NMR (100 MHz, CDCl3): δ = 144.9, 142.4, 134.5,
= 7.58 (dd, J = 7.5, 1.3 Hz, 2 H), 7.46–7.31 (m, 8 H), 3.94 (s, 3 129.8, 129.3, 129.2, 128.7, 128.6, 120.1, 101.5, 36.2, 22.0 ppm. MS
H) ppm. 13C NMR (100 MHz, CDCl3): δ = 153.2, 142.5, 138.8, (FAB): m/z = 492 [MH]+. IR (neat): ν = 2922, 1595, 1440, 1354,
˜
129.3, 129.2, 128.8, 128.7, 127.4, 125.5, 119.5, 99.3, 54.4 ppm. MS 1260, 1163, 1086, 982 cm–1. C16H15BrINO2S (492.17): calcd. C
(FAB): m/z = 458 [MH]+, 330 [M – I]+. IR (neat): ν = 2962, 1724, 39.05, H 3.07, N 2.85; found C 39.06, H 3.09, N 2.82.
˜
1627, 1492, 1435, 1311, 1265, 1218 cm–1. C16H13BrINO2 (458.09):
calcd. C 41.95, H 2.86, N 3.06; found C 41.83, H 2.87, N 2.71.
Ethyl (E)-1-(1-Bromo-2-iodo-2-phenylvinyl)-1H-indole-2-carboxyl-
ate (8): 61 % yield, 153 mg (Method A), 50 % yield, 249 mg
Methyl (E)-(1-Bromo-2-cyclohexyl-2-iodovinyl)(phenyl)carbamate
(3): 96% yield, 235 mg (Method A), 83% yield, 387 mg (Method
B), 71% yield, 329 mg (Method C) as a yellow viscous oil. 1H
NMR (400 MHz, CDCl3): δ = 7.46–7.43 (m, 2 H), 7.39–7.35 (m, 2
H), 7.28–7.25 (m, 1 H), 3.84 (s, 3 H), 2.36–2.29 (m, 1 H), 1.81–1.79
(m, 2 H), 1.74–1.70 (m, 2 H), 1.61–1.59 (m, 1 H), 1.48–1.36 (m, 4
H), 1.26–1.19 (m, 1 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
153.3, 138.8, 129.1, 126.9, 124.9, 117.5, 54.2, 47.4, 33.0, 32.8, 25.8,
(Method B), 60% yield, 300 mg (Method C) as a white solid (pre-
cipitation from dichloromethane/hexane for Method A and B;
recrystallization from ethanol for Method C). 1H NMR (400 MHz,
CDCl3): δ = 7.75 (d, J = 7.8 Hz, 1 H), 7.62–7.59 (m, 2 H), 7.53–
7.44 (m, 5 H), 7.41–7.37 (m, 1 H), 7.33–7.29 (m, 1 H), 4.47 (q, J
= 7.1 Hz, 2 H), 1.46 (t, J = 7.1 Hz, 3 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 160.6, 142.3, 137.4, 129.4, 129.0, 128.9, 127.9, 127.2,
126.9, 123.3, 123.0, 114.3, 114.1, 112.0, 99.5, 61.4, 14.8 ppm. MS
25.7 ppm. MS (FAB): m/z = 464 [MH]+, 336 [M – I]+. IR (neat): ν
(FAB): m/z = 496 [MH]+, 368, ([M – I]+). IR (neat): ν = 1708, 1534,
˜
˜
2923, 2849, 1735, 1593, 1489, 1442, 1298, 1231 cm–1.
1474, 1442, 1396, 1380, 1325, 1261, 1200, 1144 cm– 1
.
=
C16H19BrINO2 (464.14): calcd. C 41.40, H 4.13, N 3.02; found C
41.42, H 4.01, N 2.82.
C19H15BrINO2 (496.14): calcd. C 46.00, H 3.05, N 2.82; found C
45.75, H 3.02, N 2.59.
(S,E)-3-(1-Bromo-2-iodo-2-phenylvinyl)-4-phenyloxazolidin-2-one
(4): Dichloromethane was used as solvent instead of toluene that
sparingly dissolved 4. 77% yield, 180 mg (Method A), 74% yield,
349 mg (Method B), 75% yield, 353 mg (Method C) of a yellowish
solid (recrystallization from dichloromethane/methanol). 1H NMR
(400 MHz, CDCl3): δ = 7.63–7.21 (m, 8 H), 7.15 (dd, J = 7.6,
2.3 Hz, 2 H), 5.25 (dd, J = 9.2, 9.2 Hz, 1 H), 4.74 (dd, J = 9.2,
9.2 Hz, 1 H), 4.44 (dd, J = 9.2, 9.2 Hz, 1 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 153.0, 142.3, 134.2, 130.0, 129.2, 129.1,
129.0, 128.8, 128.5, 114.9, 99.2, 70.1, 62.3 ppm. MS (FAB): m/z =
(E)-1-[1-(1-Bromo-2-iodo-2-phenylvinyl)-1H-indol-3-yl]ethan-1-one
(9): 56% yield as calculated by NMR spectroscopy (Method A),
70% yield, 327 mg (Method B), 75% yield, 350 mg (Method C) as
a white solid (recrystallization from acetonitrile). 1H NMR
(400 MHz, CDCl3): δ = 8.84 (dd, J = 8.4, 1.6 Hz, 1 H), 7.89 (s, 1
H), 7.55–7.52 (m, 2 H), 7.50–7.39 (m, 6 H), 2.61 (s, 3 H) ppm. 13C
NMR (100 MHz, CDCl3): δ = 193.6, 141.8, 135.6, 133.9, 129.8,
129.0, 128.9, 126.4, 125.0, 124.2, 123.4, 120.8, 112.6, 111.6, 99.8,
28.1 ppm. MS (FAB): m/z = 466 [MH]+, 386, [M – Br]+. IR (neat):
ν = 1660, 1527, 1475, 1448, 1346, 1302, 1221 cm–1. C H BrINO
˜
18 13
469 [MH]+. IR (neat): ν = 2922, 1455, 1440, 1338, 1207, 1165, 1100,
˜
(466.12): calcd. C 46.38, H 2.81, N 3.01; found C 46.26, H 2.78, N
2.72.
1061, 1018 cm–1. C17H13BrINO2 (470.10): calcd. C 43.43, H 2.79,
N 2.98; found C 43.31, H 2.78, N 2.75.
Methyl (E)-[1-Bromo-2-iodo-2-(4-methoxyphenyl)vinyl](phenyl)-
carbamate (10): 80% yield, 206 mg (Method A), 62% yield, 249 mg
(Method B), 31% yield, 300 mg (Method C) as a white solid. 1H
NMR (400 MHz, CDCl3): δ = 7.57, (d, J = 8.2 Hz, 2 H), 7.43 (d,
J = 8.2 Hz, 2 H), 7.36–7.31 (m, 3 H), 6.87 (d, J = 8.7 Hz, 2 H),
3.93 (s, 3 H), 3.83 (s, 3 H) ppm. 13C NMR (100 MHz, [D6]acetone):
δ = 160.8, 153.3, 139.5, 135.4, 130.9 (two peaks overlapped), 129.7,
127.5, 125.5, 114.6, 100.8, 55.7, 54.3 ppm. MS (FAB): m/z = 487
[M]+. HRMS: calcd. for C17H15BrINO3 [M+] 486.9280; found
486,9255.
(E)-N-Benzyl-N-(1-bromo-2-iodo-2-phenylvinyl)-4-methylbenzene-
sulfonamide (5): 62% yield, 195 mg (Method A), 59% yield, 336 mg
(Method B), 51 % yield, 228 mg (Method C) as a white solid
(recrystallization from benzene). 1H NMR (400 MHz, CDCl3): δ =
7.94 (d, J = 8.3 Hz, 2 H), 7.50–7.48 (m, 2 H), 7.38–7.22 (m, 8 H),
7.02 (dd, J = 8.1, 1.7 Hz, 2 H), 4.83 (d, J = 12.8 Hz, 1 H), 4.00 (d,
J = 12.8 Hz, 1 H), 2.47 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3):
δ = 145.1, 143.4, 135.0, 132.9, 131.2, 123.0, 129.4, 129.0, 128.9,
128.6, 128.5, 128.1, 118.9, 104.5, 53.3, 22.0 ppm. MS (MALDI-
TOF): m/z = 567 [MH]+. IR (neat): ν = 2921, 1594, 1456, 1347,
˜
1165 cm–1. C22H19BrINO2S (568.27): calcd. C 46.50, H 3.37, N
2.46; found C 46.49, H 3.29, N 2.37.
Methyl (E)-(1,2-Diiodo-2-phenylvinyl)(phenyl)carbamate (11): 76%
1
yield, 192 mg as a yellow solid. H NMR (400 MHz, CDCl3): δ =
7.56 (dd, J = 8.5, 1.5 Hz, 2 H), 7.46–7.33 (m, 8 H), 3.94 (s, 3
H) ppm. 13C NMR (100 MHz, CD3CN): δ = 153.4, 146.0, 139.6,
130.1 (two peaks overlapped), 129.7, 129.3, 127.9, 125.9, 102.5,
98.5, 54.7 ppm. MS (FAB): m/z = 506 [MH]+, 378 [M – I]+. IR
(E)-N-Benzyl-N-[1-bromo-2-(4-cyanophenyl)-2-iodovinyl]-4-methyl-
benzenesulfonamide (6): 61 % yield as calculated by NMR spec-
troscopy (Method A), 78% yield, 462 mg (Method B) as a whitish
yellow solid (recrystallization from acetonitrile). 1H NMR
(400 MHz, CDCl3): δ = 7.92 (d, J = 8.2 Hz, 2 H), 7.58 (d, J =
8.5 Hz, 2 H), 7.48–7.46 (m, 2 H), 7.39–7.38 (m, 5 H), 7.09 (d, J =
8.2 Hz, 2 H), 4.84 (d, J = 12.9 Hz, 1 H), 3.96 (d, J = 12.9 Hz, 1
H), 2.48 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 147.8,
145.4, 134.7, 132.7, 132.6, 131.2, 130.1, 129.3, 129.2, 129.1, 128.6,
120.5, 118.6, 112.6, 101.4, 53.4, 22.1 ppm. MS (MALDI-TOF): m/z
(neat): ν = 3054, 2969, 2930, 2871, 1593, 1487, 1455, 1441 cm–1.
˜
C16H13I2NO2 (505.09): calcd. C 38.05, H 2.59, N 2.77; found C
37.91, H 2.64, N 2.70.
Methyl (E)-(1,2-Dibromo-2-phenylvinyl)(phenyl)carbamate (12):
1
61% yield, 250 mg as a white solid. H NMR (400 MHz, CDCl3):
δ = 7.34–7.16 (m, 8 H), 6.92 (d, J = 7.9 Hz, 2 H), 3.80 (s, 3 H) ppm.
13C NMR (100 MHz, CDCl3): δ = 154.3, 140.2, 138.1, 130.4, 129.6,
129.0, 128.8, 128.0, 127.2, 125.2, 123.3, 54.2 ppm. MS (FAB): m/z
= 592 [M]+. IR (neat): ν = 2222, 1594, 1495, 1456, 1346, 1164 cm–1.
˜
C23H18BrIN2O2S (593.28): calcd. C 46.56, H 3.06, N 4.72; found
C 46.56, H 3.07, N 4.57.
= 412 [MH]+, 330 [M – Br]+. IR (neat): ν = 1724, 1490, 1435, 1321,
˜
(E)-N-(1-Bromo-2-iodo-2-phenylvinyl)-N,4-dimethylbenzenesulfon- 1254, 1223, 1195, 1161, 1059 cm–1. C16H13Br2NO2 (411.09): calcd.
amide (7): 47% yield as calculated by NMR spectroscopy (Method C 46.75, H 3.19, N 3.41; found C 46.59, H 3.24, N 3.13.
3266
www.eurjoc.org
© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2014, 3262–3267